Osteonecrosis of the jaw
Martwica żuchwy

Bogna Drozdzowska
2011 Endokrynologia Polska  
The paper concerns osteonecrosis of the jaw (ONJ). It is a rare but serious clinical condition. It can develop in patients treated in oncologic doses with bisphosphonates but also with denosumab. In osteoporosis ONJ seems to be very rare. Definition, pathogenesis, risk factors, prevention and treatment, and the frequency of ONJ are presented.
pmid:22161980 fatcat:lxfmwrxpqfgq5kunpjo56o5rma